A high-throughput liquid chromatography tandem mass spectrometry method for the comparative determination of fluticasone propionate by reversed-phase liquid chromatography and capillary electrophoresis methods in pharmaceutical nasal sprays

European Journal of Mass Spectrometry

Volumn 15, Issue 6, 2009, Pages 723-730

  Da Silva Sangoi, Maximiliano ^a   Wrasse, Micheli ^b   D'avila, Felipe Bianchini ^b   Bernardi, Raquel Martini ^a   De Oliveira, Paulo Renato ^c   Dalmora, Sérgio Luiz ^b   Rolim, Clarice Madalena Bueno ^b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^c FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Capillary electrophoresis; Fluticasone propionate; Liquid chromatography; Tandem mass spectrometry; Validation

Indexed keywords

ANDROSTANE DERIVATIVE; ANTIALLERGIC AGENT; ANTIINFLAMMATORY AGENT; DEFLAZACORT; FLUTICASONE; PREGNANE DERIVATIVE;

ARTICLE; CAPILLARY ELECTROPHORESIS; HUMAN; INTRANASAL DRUG ADMINISTRATION; LIQUID CHROMATOGRAPHY; METHODOLOGY; STANDARD; TANDEM MASS SPECTROMETRY; VALIDATION STUDY;

ADMINISTRATION, INTRANASAL; ANDROSTADIENES; ANTI-ALLERGIC AGENTS; ANTI-INFLAMMATORY AGENTS; CHROMATOGRAPHY, LIQUID; ELECTROPHORESIS, CAPILLARY; HUMANS; PREGNENEDIONES; REFERENCE STANDARDS; TANDEM MASS SPECTROMETRY;

EID: 73649147363     PISSN: 14690667     EISSN: None     Source Type: Journal    
DOI: 10.1255/ejms.1044     Document Type: Article

References (28)

1. P. J. Barnes. S. Pedersen and W. W. Busse, "Efficacy and safety of inhaled corticosteroids", Am. J. Respir. Crit. Care Med. 157, S1-S53 (1998).
2. R. Dahl, L. P. Nielsen. J. Kips, A. Foresi, P. van Cauwenberge, N. Tudoric, P. Howarth, D. H. Richards, M. Williams and R. Pauwels, "Intranasal and inhaled fluticasone propionate for pollen-induced rhinitis and asthma", Allergy 60, 875-881 (2005). doi: 10.1111/j.1398-9995.2005.00819.x
3. S. J. Szefler, "Pharmacokinetics of intranasal corticosteroids" , J. Allergy Clin. Immunol. 108, S26-S31 (2001). doi: 10.1067/mai.2001.115563
4. M. Frieri, "Inflammatory issues in allergic rhinitis and asthma", Allergy Asthma Proc. 26, 163-169 (2005).
5. B. M. Prenner and E. Schenkel, "Allergic rhinitis: treatment based on patient profiles", Am. J. M Ed. 119, 230-237 (2006). doi: 10.1016/j.amjmed.2005.06.015
6. B. M. Bain. G. Harrison, K. D. Jenkins, A. J. Pateman and E. V. B. Shenoy, "A sensitive radioimmunoassay, incorporating solid-phase extraction, for fluticasone 17-propionate in plasma", J. Pharm. Biomed. Anal. 11, 557-561 (1993). doi: 10.1016/0731-7085 (93) 80005-L
7. Y. N. Li, B. N. Tattam, K. F. Brown and J. P. Seale, "A sensitive method for the quantification of fluticasone propionate in human plasma by high-performance liquid chromatography/atmospheric pressure chemical ionisation mass spectrometry", J. Pharm. Biomed. Anal. 16, 447-452 (1997). doi: 10.1016/S0731-7085 (97) 00073-3
8. S. L Callejas, R. A. Biddlecombe, A. E. Jones, K. B. Joyce, A. I. Pereira and S. Pleasance, "Determination of the glucocorticoid fluticasone propionate in plasma by automated solid-phase extraction and liquid chromatography-tandem mass spectrometry", J. Chromatogr. B 718, 243-250 (1998). doi: 10.1016/S0378-4347 (98) 00374-0
9. L Laugher, T. G. Noctor, A. Barrow, J. M. Oxford and T. Phillips, "An improved method for the determination of fluticasone propionate in human plasma", J. Pharm. Biomed. Anal. 21, 749-758 (1999). doi: 10.1016/S0731-7085 (99) 00213-7
10. S. Krishnaswami, H. Möllmann, H. Derendorf and G. Hochhaus, "A sensitive LC-MS/MS method for the quantification of fluticasone propionate in human plasma", J. Pharm. Biomed. Anal. 22, 123-129 (2000). doi: 10.1016/S0731-7085 (99) 00246-0
11. R. L. Taylor, S. K. Grebe and R. J. Singh, "Quantitative, highly sensitive liquid chromatography-tandem mass spectrometry method for the detection of synthetic corticosteroids". Clin. Chem. 50, 2345-2352 (2004). doi: 10.1373/clinchem.2004.033605
12. H. J. Mascher, K. Zech and D. G. Mascher, "Sensitive determination of ciclesonide, ciclesonide-M1-metabolite and fluticasone propionate in human serum by HPLC-MS/MS with APPI", J. Chromatogr. B 869, 84-92 (2008). doi: 10.1016/j.jchromb.2008.05.015
13. D. Murname, G. P. Martin and C. Marriot, "Validation of a reverse-phase high performance liquid chromatographic method for concurrent assay of a weak base (salmeterol xinafoate) and a pharmacologically active steroid (fluticasone propionate)", J. Pharm. Biomed. Anal. 40, 1149-1154 (2006). doi: 10.1016/j. jpba.2005.09.028
14. J. L. Bernal. M. J. Nozal, M. T. Martín. J. C. Diez-Masa and A. Cifuentes, "Quantitation of active ingredients and excipients in nasal sprays by high-performance liquid chromatography, capillary electrophoresis and UV spectroscopy", J. Chromatogr. A 823, 423-431 (1998). doi: 10.1016/S0021-9673 (98) 00451-8
15. M. S. Sangoi, D. R. Nogueira, L. M. Silva, D. P. Leal and S. L. Dalmora. "Validation of a stability-indicating reversed-phase LC method for the determination of fluticasone propionate in pharmaceutical formulations", J. Liq. Chromatogr. Rel. Technol. 31, 2113-2127 (2008). doi: 10.1080/10826070802225395
16. M. S. Sangoi, L. M. Silva, F. B. D'Avila and S. L. Dalmora, "Determination of fluticasone propionate in nasal sprays by a validated stability-indicating micellar electrokinetic chromatography method", J. Chromatogr. Sc. (2009) in press.
17. H. Lee, "Pharmaceutical applications of liquid chromatography coupled with mass spectrometry (LC/MS)", J. Liq. Chromatogr. Rel. Technol. 28, 1161-1202 (2005). doi: 10.1081/JLC-200053022
18. C.-K. Lim and G. Lord, "Current developments in LC-MS for pharmaceutical analysis", Biol. Pharm. Bull. 25, 547-557 (2002). doi: 10.1248/bpb.25.547
19. R. Ventura, M. Roig, N. Monfort, P. Sáez, R. Bergés and J. Segura, "High-throughput and sensitive screening by ultra-performance liquid chromatography tandem mass spectrometry of diuretics and other doping agents", Eur. J. Mass Spectrom. 14 (3), 191-200 (2008). doi: 10.1255/ejms.920
20. X. Xu. H. Mei, S. Wang. Q. Zhou, G. Wang, L. Broske, A. Pena and W. A. Korfmacher, "A study of common discovery dosing formulation components and their potential for causing time-dependent matrix effects in high-performance liquid chromatography tandem mass spectrometry assays", Rapid Commun. Mass Spectrom. 19, 2643-2650 (2005). dot: 10.1002/rcm.2102
21. N. Lindegardh, A. M. Dondorp, P. Singhasivanon, N. J. White and N. P. J. Day, "Validation and application of a liquid chromatographic-mass spectrometric method for determination of artesunate in pharmaceutical samples", J. Pharm. Biomed. Anal. 45, 149-153 (2007). doi: 10.1016/j. jpba.2007.04.030
22. X. Feás, L. Ye. S. V. Hosseini, C. A. Fente and A. Cepeda, "Development and validation of LC-MS/MS method for the determination of cyproheptadine in several pharmaceutical syrup formulations", J. Pharm. Biomed. Anal. 50, 1044-1049 (2009). doi: 10.1016/j.jpba.2009.06.006
23. S. Görög, "Drug safety, drug quality, drug analysis", J. Pharm. Biomed. Anal. 48, 247-253 (2008). doi: 10.1016/j. jpba.2007.10.038
24. E. Rozet, A. Ceccato, C. Hubert, E. Ziemons, R. Oprean, S. Rudaz, B. Boulanger and P. Hubert, "Analysis of recent pharmaceutical regulatory documents on analytical method validation", J. Chromatogr. A 1158, 111-125 (2007). doi: 10.1016/j.chroma.2007.03.111
25. G. A. Shabir, W. J. Lough, S. A. Arain and T. K. Bradshaw, "Evaluation and application of best practice in analytical method validation", J. Liq. Chromatogr. Rel. Technol. 30, 311-333 12007). doi: 10.1080/10826070601084753
26. Validation of Analytical Procedures: Text and Methodology Q2 (R1). ICH Harmonised Tripartite Guidelines, November 2005.
27. W. M. Niessen, "Progress in liquid chromatographymass spectrometry instrumentation and its impact on high-throughput screening", J. Chromatogr. A. 1000, 413-436 (2003). doi: 10.1016/S0021-9673 (03) 00506-5
28. Z. Li, High throughput analysis in support of process chemistry and formulation research and development in the pharmaceutical industry, in High Throughput Analysis in the Pharmaceutical Industry, Ed by P. G. Wang Editor, CRC Press, Boca Raton, FL, USA, pp. 247-278 (2009).